Increased visceral adipose tissue mass is associated with increased C-reactive protein in patients with manifest vascular diseases

Atherosclerosis

Volumn 212, Issue 1, 2010, Pages 274-280

  Faber, Daniël R ^a   van der Graaf, Yolanda ^a   Westerink, Jan ^a   Visseren, Frank L J ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Adipose tissue; C reactive protein; Inflammation; Insulin resistance; Vascular disease

Indexed keywords

C REACTIVE PROTEIN;

ABDOMINAL OBESITY; ADULT; ARTERY DISEASE; ARTICLE; BODY MASS; CROSS-SECTIONAL STUDY; ECHOGRAPHY; FEMALE; HUMAN; INSULIN RESISTANCE; INTRAABDOMINAL FAT; LINEAR REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; METABOLIC PARAMETERS; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; SMOKING; SUBCUTANEOUS FAT; VASCULAR DISEASE; WAIST CIRCUMFERENCE;

ADIPOSITY; AGED; ATHEROSCLEROSIS; BIOLOGICAL MARKERS; BODY MASS INDEX; C-REACTIVE PROTEIN; CROSS-SECTIONAL STUDIES; FASTING; FEMALE; HUMANS; INFLAMMATION; INFLAMMATION MEDIATORS; INSULIN RESISTANCE; INTRA-ABDOMINAL FAT; LINEAR MODELS; MALE; MIDDLE AGED; NETHERLANDS; OBESITY; PROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SUBCUTANEOUS FAT, ABDOMINAL; UP-REGULATION; WAIST CIRCUMFERENCE;

EID: 77956232053     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2010.04.029     Document Type: Article

References (30)

1. Yusuf S., Hawken S., Ounpuu S., et al. Obesity and the risk of myocardial infarction in 27,000 participants from 52 countries: a case-control study. Lancet 2005, 366:1640-1649.
2. Festa A., D'Agostino R., Williams K., et al. The relation of body fat mass and distribution to markers of chronic inflammation. Int J Obes Relat Metab Disord 2001, 25:1407-1415.
3. Rexrode K.M., Pradhan A., Manson J.E., Buring J.E., Ridker P.M. Relationship of total and abdominal adiposity with CRP and IL-6 in women. Ann Epidemiol 2003, 13:674-682.
4. Tilg H., Moschen A.R. Adipocytokines: mediators linking adipose tissue, inflammation and immunity. Nat Rev Immunol 2006, 6:772-783.
5. Curat C.A., Wegner V., Sengenes C., et al. Macrophages in human visceral adipose tissue: increased accumulation in obesity and a source of resistin and visfatin. Diabetologia 2006, 49:744-747.
6. Shi H., Kokoeva M.V., Inouye K., et al. TLR4 links innate immunity and fatty acid-induced insulin resistance. J Clin Invest 2006, 116:3015-3025.
7. Trayhurn P., Wang B., Wood I.S. Hypoxia and the endocrine and signalling role of white adipose tissue. Arch Physiol Biochem 2008, 114:267-276.
8. Ozcan U., Cao Q., Yilmaz E., et al. Endoplasmic reticulum stress links obesity, insulin action, and type 2 diabetes. Science 2004, 306:457-461.
9. Faber D.R., de Groot P.G., Visseren F.L. Role of adipose tissue in haemostasis, coagulation and fibrinolysis. Obes Rev 2009.
10. Fain J.N., Madan A.K., Hiler M.L., Cheema P., Bahouth S.W. Comparison of the release of adipokines by adipose tissue, adipose tissue matrix, and adipocytes from visceral and subcutaneous abdominal adipose tissues of obese humans. Endocrinology 2004, 145:2273-2282.
11. Fontana L., Eagon J.C., Trujillo M.E., Scherer P.E., Klein S. Visceral fat adipokine secretion is associated with systemic inflammation in obese humans. Diabetes 2007, 56:1010-1013.
12. Ridker P.M., Hennekens C.H., Buring J.E., Rifai N. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med 2000, 342:836-843.
13. Ray K.K., Cannon C.P., Cairns R., et al. Prognostic utility of apoB/AI, total cholesterol/HDL, non-HDL cholesterol, or hs-CRP as predictors of clinical risk in patients receiving statin therapy after acute coronary syndromes: results from PROVE IT-TIMI 22. Arterioscler Thromb Vasc Biol 2009, 29:424-430.
14. Pearson T.A., Mensah G.A., Alexander R.W., et al. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation 2003, 107:499-511.
15. Forouhi N.G., Sattar N., McKeigue P.M. Relation of C-reactive protein to body fat distribution and features of the metabolic syndrome in Europeans and South Asians. Int J Obes Relat Metab Disord 2001, 25:1327-1331.
16. Lemieux I., Pascot A., Prud'homme D., et al. Elevated C-reactive protein: another component of the atherothrombotic profile of abdominal obesity. Arterioscler Thromb Vasc Biol 2001, 21:961-967.
17. Pou K.M., Massaro J.M., Hoffmann U., et al. Visceral and subcutaneous adipose tissue volumes are cross-sectionally related to markers of inflammation and oxidative stress: the Framingham Heart Study. Circulation 2007, 116:1234-1241.
18. Saijo Y., Kiyota N., Kawasaki Y., et al. Relationship between C-reactive protein and visceral adipose tissue in healthy Japanese subjects. Diabetes Obes Metab 2004, 6:249-258.
19. Sam S., Haffner S., Davidson M.H., et al. Relation of abdominal fat depots to systemic markers of inflammation in type 2 diabetes. Diabetes Care 2009, 32:932-937.
20. Simons P.C., Algra A., van de Laak M.F., Grobbee D.E., van der Graaf Y. Second manifestations of ARTerial disease (SMART) study: rationale and design. Eur J Epidemiol 1999, 15:773-781.
21. Stolk R.P., Wink O., Zelissen P.M., et al. Validity and reproducibility of ultrasonography for the measurement of intra-abdominal adipose tissue. Int J Obes Relat Metab Disord 2001, 25:1346-1351.
22. Stolk R.P., Meijer R., Mali W.P., Grobbee D.E., van der Graaf Y. Ultrasound measurements of intraabdominal fat estimate the metabolic syndrome better than do measurements of waist circumference. Am J Clin Nutr 2003, 77:857-860.
23. Thorand B., Baumert J., Doring A., et al. Sex differences in the relation of body composition to markers of inflammation. Atherosclerosis 2006, 184:216-224.
24. Weisberg S.P., McCann D., Desai M., et al. Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 2003, 112:1796-1808.
25. Cinti S., Mitchell G., Barbatelli G., et al. Adipocyte death defines macrophage localization and function in adipose tissue of obese mice and humans. J Lipid Res 2005, 46:2347-2355.
26. Harman-Boehm I., Bluher M., Redel H., et al. Macrophage infiltration into omental versus subcutaneous fat across different populations: effect of regional adiposity and the comorbidities of obesity. J Clin Endocrinol Metab 2007, 92:2240-2247.
27. Fasshauer M., Klein J., Lossner U., Paschke R. Interleukin (IL)-6 mRNA expression is stimulated by insulin, isoproterenol, tumour necrosis factor alpha, growth hormone, and IL-6 in 3T3-L1 adipocytes. Horm Metab Res 2003, 35:147-152.
28. Krogh-Madsen R., Moller K., Dela F., et al. Effect of hyperglycemia and hyperinsulinemia on the response of IL-6, TNF-alpha, and FFAs to low-dose endotoxemia in humans. Am J Physiol Endocrinol Metab 2004, 286:E766-E772.
29. Krogh-Madsen R., Plomgaard P., Keller P., Keller C., Pedersen B.K. Insulin stimulates interleukin-6 and tumor necrosis factor-alpha gene expression in human subcutaneous adipose tissue. Am J Physiol Endocrinol Metab 2004, 286:E234-E238.
30. Ruge T., Lockton J.A., Renstrom F., et al. Acute hyperinsulinemia raises plasma interleukin-6 in both nondiabetic and type 2 diabetes mellitus subjects, and this effect is inversely associated with body mass index. Metabolism 2009, 58:860-866.